Product logins

Find logins to all Clarivate products below.


Blog: Pharma

Here you will find relevant articles and insight into all Clarivate related products and news.

Why longevity might be biopharma's next big thing: The science and business converge Why longevity might be biopharma's next big thing: The science and business converge
Blog March 2, 2026
Why longevity might be biopharma's next big thing: The science and business converge
Biopharma Biotech Business Development
The path forward: What comes after a CRL? The path forward: What comes after a CRL?
Blog February 24, 2026
The path forward: What comes after a CRL?
Biopharma Biotech Clinical trials
Relacorilant:  when evidence meets the established evidence bar Relacorilant:  when evidence meets the established evidence bar
Blog February 24, 2026
Relacorilant: when evidence meets the established evidence bar
Biopharma Biotech Clinical trials
Tolebrutinib: when safety concerns override efficacy signals Tolebrutinib: when safety concerns override efficacy signals
Blog February 24, 2026
Tolebrutinib: when safety concerns override efficacy signals
Biopharma Biotech Clinical trials
Navigating Complete Response Letters: how Clarivate solutions can help pharmas chart their path to approval Navigating Complete Response Letters: how Clarivate solutions can help pharmas chart their path to approval
Blog February 24, 2026
Navigating Complete Response Letters: how Clarivate solutions can help pharmas chart their path to approval
Biopharma Biotech Clinical trials
How the Inflation Reduction Act could impact access to more convenient therapeutics How the Inflation Reduction Act could impact access to more convenient therapeutics
Blog February 17, 2026
How the Inflation Reduction Act could impact access to more convenient therapeutics
Biopharma Biotech Commercialization
What healthcare payers reward: adherence versus outcomes What healthcare payers reward: adherence versus outcomes
Blog February 2, 2026
What healthcare payers reward: adherence versus outcomes
Biopharma HMO IDN
Forecasting target markets using epidemiology data: how Clarivate does it Forecasting target markets using epidemiology data: how Clarivate does it
Blog December 8, 2025
Forecasting target markets using epidemiology data: how Clarivate does it
Biotech Epidemiology Pharma

Pharma

온디맨드 웨비나 사이트런칭 온디맨드 웨비나 사이트런칭
Blog March 15, 2022
온디맨드 웨비나 사이트런칭
Why longevity might be biopharma's next big thing: The science and business converge Why longevity might be biopharma's next big thing: The science and business converge
Blog March 2, 2026
Why longevity might be biopharma's next big thing: The science and business converge
The path forward: What comes after a CRL? The path forward: What comes after a CRL?
Blog February 24, 2026
The path forward: What comes after a CRL?
Relacorilant:  when evidence meets the established evidence bar Relacorilant:  when evidence meets the established evidence bar
Blog February 24, 2026
Relacorilant: when evidence meets the established evidence bar
Tolebrutinib: when safety concerns override efficacy signals Tolebrutinib: when safety concerns override efficacy signals
Blog February 24, 2026
Tolebrutinib: when safety concerns override efficacy signals
Navigating Complete Response Letters: how Clarivate solutions can help pharmas chart their path to approval Navigating Complete Response Letters: how Clarivate solutions can help pharmas chart their path to approval
Blog February 24, 2026
Navigating Complete Response Letters: how Clarivate solutions can help pharmas chart their path to approval
How the Inflation Reduction Act could impact access to more convenient therapeutics How the Inflation Reduction Act could impact access to more convenient therapeutics
Blog February 17, 2026
How the Inflation Reduction Act could impact access to more convenient therapeutics
What healthcare payers reward: adherence versus outcomes What healthcare payers reward: adherence versus outcomes
Blog February 2, 2026
What healthcare payers reward: adherence versus outcomes
Forecasting target markets using epidemiology data: how Clarivate does it Forecasting target markets using epidemiology data: how Clarivate does it
Blog December 8, 2025
Forecasting target markets using epidemiology data: how Clarivate does it
Machine curation in action: a new approach to essential tremor epidemiology Machine curation in action: a new approach to essential tremor epidemiology
Blog November 17, 2025
Machine curation in action: a new approach to essential tremor epidemiology
Six companies enabling precision interventions for “undruggable” targets Six companies enabling precision interventions for “undruggable” targets
Blog October 7, 2025
Six companies enabling precision interventions for “undruggable” targets